Expert multidisciplinary clinical diagnosis and individualized disease-modifying therapy for Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis (IPF), Hypersensitivity Pneumonitis, and connective tissue autoimmune lung disease at KIMS Super Speciality Hospital, Electronic City, Bangalore.
High-precision diagnostics, cutting-edge medical technologies, and evidence-based treatment pathways tailored for individual patient outcomes.
Interstitial Lung Disease (ILD) comprises a diverse group of over 200 distinct pulmonary disorders characterized by progressive inflammation and irreversible scarring (fibrosis) of the interstitium—the microscopic tissue scaffolding that supports the delicate air sacs (alveoli). As the interstitial tissue thickens and stiffens, the lungs lose their elastic compliance and ability to transfer oxygen into the bloodstream.
Accurate differentiation between idiopathic pulmonary fibrosis (IPF), environmental hypersensitivity pneumonitis, and autoimmune connective tissue-related ILD is critical for clinical preservation of lung capacity. The ILD program integrates volumetric high-resolution CT imaging, transbronchial cryobiopsy histopathology, antifibrotic pharmacotherapy, and timely lung transplant referral.
Recognizing clinical signs and diagnostic triggers that indicate the need for specialized pulmonary review.
A chronic dry cough lasting for more than 2-3 months that fails to respond to common cough syrups, antibiotics, or allergy antihistamines.
Shortness of breath that creeps up over months—initially noticed only when climbing stairs or brisk walking, but gradually progressing to simple household chores.
Characteristic dry, fine, end-inspiratory sounds resembling the peeling apart of Velcro heard through the stethoscope over the lower lung bases.
Painless enlargement and bulbous rounding of the fingertips and toes with increased curvature of the nail beds caused by chronic tissue hypoxia.
Dropping oxygen saturation from a normal resting 96-98% down to 85-88% within 2 to 3 minutes of brisk walking on a flat surface.
Cold fingers turning blue or white in cold water (Raynaud’s phenomenon), joint swelling, or skin tightening indicating underlying connective tissue disease (CTD-ILD).
Advanced medical and surgical equipment providing high-yield diagnostic precision and life-saving therapeutic interventions.
Volumetric thin-slice (1 mm) inspiratory and expiratory chest imaging without contrast. Identifies diagnostic radiological hallmarks: reticulation, traction bronchiectasis, ground-glass opacities, and classic subpleural basal honeycombing.
When HRCT patterns are ambiguous, flexible bronchoscopic cryobiopsy extracts substantial, non-crushed alveolar tissue specimens under sedation, providing histological certainty without the trauma and morbidity of surgical thoracotomy.
Prescription and careful monitoring of approved antifibrotic oral agents (Nintedanib / Pirfenidone) for Idiopathic Pulmonary Fibrosis and progressive fibrosing ILDs. Directly inhibits fibroblast proliferation and slows the decline in Forced Vital Capacity (FVC) by over 50%.
Comprehensive screening for autoimmune rheumatic markers (ANA by IFA, extended ENA 17-antigen immunoblot, myositis profile, rheumatoid factor, anti-CCP), treating autoimmune ILD with targeted immunosuppressants (Mycophenolate Mofetil, Rituximab).
Standardized clinical walk protocol with continuous pulse oximetry tracking exertional desaturation, distance walked, and recovery time, tailoring pulse-dose portable oxygen therapy for active daily ambulation.
Because idiopathic pulmonary fibrosis can progress unpredictably, the clinical teamintegrates early candidate workup and listing for bilateral lung transplantation, providing seamless bridging support at KIMS Hospitals.
How we guide every patient from initial assessment to definitive treatment and long-term functional recovery.
Thorough exploration of symptom duration, bird and pigeon exposure (balcony nets, droppings), indoor dampness, mold, medications, and joint symptoms.
Thin-slice HRCT scan, full spirometry with DLCO (diffusion capacity for carbon monoxide), and 6-minute walk test to determine physiological impairment.
Collaborative consensus review between pulmonologist, dedicated thoracic radiologist, and pathologist to arrive at a definitive diagnosis.
Commencement of disease-modifying therapy, patient education on dietary tolerance, ambulatory oxygen setup, and pulmonary rehab enrollment.
Clear, clinically accurate answers to common patient questions regarding this pulmonary specialty.
Established fibrotic scar tissue cannot be erased or reversed back into normal spongy lung tissue. However, modern antifibrotic medications (Nintedanib and Pirfenidone) significantly slow down further scar formation, halving the rate of lung capacity decline and preserving your remaining functional lung volume.
Bird Fancier’s Lung is a form of Hypersensitivity Pneumonitis triggered by inhaling aerosolized microscopic proteins from bird droppings and feathers—most commonly from pigeons nesting on apartment air-conditioner ledges and balconies in urban Bangalore. It is extremely common, often misdiagnosed as routine asthma, and requires strict pigeon avoidance and early anti-inflammatory treatment.
Because over 200 conditions cause lung fibrosis and their treatments differ dramatically (IPF requires antifibrotics and is harmed by high-dose steroids, whereas autoimmune ILD requires immunosuppressants), international guidelines mandate an MDD where the pulmonologist, specialized chest radiologist, and lung pathologist review the case together to reach the correct diagnosis.
For Idiopathic Pulmonary Fibrosis (IPF), guidelines recommend referral for lung transplant evaluation at the time of initial diagnosis, regardless of current symptoms, because disease progression can be unpredictable. For other ILDs, referral is indicated when lung capacity declines by > 10% over 6 months or when supplemental oxygen is first required.
Antifibrotics are oral capsules taken daily with meals. The most common side effects are gastrointestinal (nausea, mild diarrhea, loss of appetite) or sun sensitivity. Under proactive dietary protocols and dose titration, the vast majority of patients tolerate treatment well and continue their normal daily routines.
Consultation Specialty: Interstitial Lung Disease (ILD)
